Vima Therapeutics Revenue
Biotechnology Research • 
United States • 11-20 Employees
Vima Therapeutics revenue & valuation
| Annual revenue | $1,283,325 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $4,200,000 |
| Total funding | $60,000,000 |
Key Contacts at Vima Therapeutics
Bernard Ravina
Chief Executive Officer
Nicole Carlson
Director Clinical Operations
Company overview
| Headquarters | United States |
| Website | |
| NAICS | 541714 |
| Employees | 11-20 |
| Socials |
Vima Therapeutics Email Formats
Vima Therapeutics uses 3 email formats. The most common is {first name} (e.g., john@vimatx.com), used 50% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@vimatx.com | 50% |
{first name}{last name} | johndoe@vimatx.com | 42.9% |
{first initial} | j@vimatx.com | 7.1% |
About Vima Therapeutics
Vima Therapeutics is a clinical-stage biotechnology company pioneering a new era in the treatment of dystonia and related movement disorders. We are advancing VIM0423, a potential first-in-class oral therapy for dystonia, with the goal of helping individuals regain control of their movements by targeting the underlying cause of the disease. Vima brings together a team of physicians, scientists, and drug developers with deep expertise in movement disorders and a shared commitment to deliver a meaningful oral therapy for patients.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Vima Therapeutics has 9 employees across 5 departments.
Departments
Number of employees
Croatia
United Kingdom
India
Frequently asked questions
4.8
40,000 users
